Safety Rates Drug Report: RIBAVIRIN. Stent placement adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: RIBAVIRIN. Injury: Stent placement Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 2 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
125609103	RIBAVIRIN.	Stent placement	BRISTOL MYERS SQUIBB	60.00 YR	M	99 KG	20160803	US
125911071	RIBAVIRIN.	Stent placement	MERCK	60.00 YR	M	73 KG	20160726	TR

|< 1/2 << Previous Page Page 1

Total Records: 2 Number of Pages: 1

Execution Time: 0.02869701385498 seconds (ucode:5059583). Developed by: James D. Barger